MedPath

Adam Olszewski

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Removing Transfusion Dependence as a Barrier to Hospice Enrollment

Not Applicable
Active, not recruiting
Conditions
Myeloma
Myelodysplastic Syndromes
Hematologic Malignancy
Lymphoma
Acute Myeloid Leukemia
Leukemia
First Posted Date
2021-10-01
Last Posted Date
2023-02-08
Lead Sponsor
Adam Olszewski
Target Recruit Count
20
Registration Number
NCT05063591
Locations
🇺🇸

Rhode Island Hospital, Providence, Rhode Island, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.